Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast


Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Database Update: Import of Pharmaceutical Drugs Made in EEU Countries to Russia (April 2019)

Friday, May 24, 2019

Between January and April 2019, Russia imported over 3.6 bln RUB worth of pharmaceutical drugs made in the EEU countries (wholesale prices, VAT included), which is in monetary terms (rubles) 37.8% higher than that of the same period in 2018. In physical terms (units), the dynamics are +46.3%, with 85.4 mln units of pharmaceuticals.

Despite the impressive dynamics, the growth rates in April 2019 somewhat slowed down in both monetary and physical terms. However, the EEU manufacturers and their Russian partners are way ahead of Russian manufacturers in terms of activity, despite the increasing state procurements earlier this year.

The import line for the period underwent little to no change. This is true only for trademarks though; the dosage form list has grown considerably. Between January and April 2019, Russia imported 174 different SKU, while it was 161 in 2018. Among the new drugs on the list, Viasan-LF (Sildenafil) by Lekpharm (Belarus) and Sevoflurane-Vial by Alvils Holding (Russia), which is also manufactured by Pharmland (Belarus), are noteworthy.

The top 3 companies are still the same: Belmedpreparaty (Belarus) with 35% of the total EEU import, Borisov Plant of Medical preparations (Belarus) with 27%, and Kelun Group (Kazakhstan) with 15%. Dynamics are inversely proportional to share in the total import. The import of Kelun Group has increased by 5 times in monetary terms, while the import dynamics of Belmedpreparaty are only +4%, and the import dynamics of Borisov Plant of Medical preparations are +37%.

As for trademarks, the absolute leader is Sodium Chloride, 97% of which is exported to Russia by Kelun Group. It is also the company’s key product exported to Russia. The import of Glucose has grown by 29 times in monetary terms; it has the highest dynamics for the first 4 months of 2019.

Read more about import of pharmaceutical drugs from EEU countries to Russia (March 2019) here:

Dynamics and volume of import of pharmaceutical drugs made in the EEU countries to Russia, wholesale prices, VAT included (2016 – 2018, January – April 2019)